Ferring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position in gastroenterology.
Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy.